health-news

'Alzheimer's drug to be developed within five years'

Washington, Dec. 5 : Scientists have said that a drug that could provide a breakthrough for Alzheimer's disease will be available within the next five years.


Recruitment of people aged 55 - 90 to take part in the final-stage study in the US is taking place. The study will examine if the drug solanezumab slows the cognitive and functional decline of people who suffer from mild Alzheimer's.

In the new trial expected to end by December 2016, people are going to be given solanezumab as a monthly 400mg injection for 18 months.

Dr Eric Karran, director of research at Alzheimer's Research UK, said that the results would suggest that monthly injections should be given early to ward off the disease, News.com.au reported.

Dr Karran said that the drug showed "reasonable" effect in people suffering from mild Alzheimer's and results would come within five years.

--ANI (Posted on 05-12-2013)

health-news headlines

'Unproven treatment of spinal injuries can cause paralysis'

Can too much exercise be a bad thing?

New method to treat cocaine addiction effectively

Aspirin can lower colorectal cancer risks for people with specific gene

Aspirin may cut down colon cancer risks too

Prenatal smoking linked to enhanced aggressive behavior in children

Novel compound could halt cocaine addiction and relapse behaviors

Red meat could up heart disease risk

Vitamin D supplements have little effect on risk of falls among older people: Lancet

Marijuana use could up heart complications in young, middle-aged adults

Acupuncture improves activation of functional brain areas in stroke sufferers

Binge drinking could make you overeat

Quick Links: Goa | Munnar | Pondicherry | Free Yearly Horoscope '2014

Comments

Your e-mail:


Your Full Name:


Type verification image:
verification image, type it in the box

Message:

Back to Top